Perbedaan Ikapharmindo Putramas Tbk. dan Organon Pharma Indonesia Tbk.: Ikapharmindo Putramas Tbk. diperdagangkan di Rp183 (kapitalisasi pasar 313,35 M, volume 24 jam 1,41 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Ikapharmindo Putramas Tbk. jauh lebih besar — sekitar 3× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| IKPM | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 313,35 M | 104,4 M |
Volume | 1,41 jt | — |
Lot | 14,1 rb | — |
Perputaran | 271,25 jt | — |
Harga Rata-rata | 192,33 | — |
Nilai Transaksi | 271,25 jt | — |
Harga Ekuilibrium Indikatif | 186 | — |
Volume Ekuilibrium Indikatif | 600 | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Selengkapnya di halaman IKPM →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →